[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Suppr

超能文献

作者信息

Birkmayer W, Mentasti M

出版信息

Arch Psychiatr Nervenkr (1970). 1967 Aug 8;210(1):29-35. doi: 10.1007/BF01217333.

DOI:10.1007/BF01217333

PMID:4292871

Abstract

摘要

相似文献

[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Arch Psychiatr Nervenkr (1970). 1967 Aug 8;210(1):29-35. doi: 10.1007/BF01217333.

[Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].[在患有抑郁和帕金森综合征的患者中，与左旋多巴和地昔帕明相关的脱羧酶抑制剂作用下儿茶酚胺代谢的改变]

Encephale. 1971 May-Jun;60(3):189-209.

[Experimental findings and new aspects in extrapyramidal diseases].

Wien Z Nervenheilkd Grenzgeb. 1966;23(1):128-39.

[Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].

Presse Med (1893). 1969 Apr 5;77(17):617-8.

Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.外周脱羧酶抑制后，3,4-二羟基苯丙氨酸引起脑内儿茶酚胺增加。

Nature. 1967 Aug 19;215(5103):852-3. doi: 10.1038/215852b0.

[Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].

Arch Int Pharmacodyn Ther. 1969 Aug;180(2):423-37.

Hyperactive states related to the metabolism of norepinephrine and similar biochemicals.

Ann N Y Acad Sci. 1969 Jul 30;159(3):939-58. doi: 10.1111/j.1749-6632.1969.tb12990.x.

Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.帕金森病中的外周芳香族L-氨基酸脱羧酶抑制剂。II. 对L-2-¹⁴C-多巴代谢的影响

Clin Pharmacol Ther. 1972 Jul-Aug;13(4):584-94. doi: 10.1002/cpt1972134584.

Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.

J Pharmacol Exp Ther. 1961 Jun;132:278-86.

[Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].[由于外周脱羧酶抑制导致脑内C14-儿茶酚胺的选择性增加]

Helv Physiol Pharmacol Acta. 1967;25(2):CR170-2.

引用本文的文献

Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.左旋多巴治疗：贯穿帕金森病进展过程中的影响及机制。

J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.

A qualitative study exploring the clinical phenomenology and impact of hypersexuality in patients with Parkinson's Disease.一项探索帕金森病患者性欲亢进的临床现象学及其影响的定性研究。

Sci Rep. 2024 Nov 20;14(1):28697. doi: 10.1038/s41598-024-79966-z.

Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary Data.脑炎后帕金森病：独特的病理和临床特征——初步数据。

Cells. 2024 Sep 10;13(18):1511. doi: 10.3390/cells13181511.

Clinicians' viewpoints on current paradigms of care and research in Parkinson's disease.临床医生对帕金森病当前护理和研究范式的观点。

J Neural Transm (Vienna). 2024 Dec;131(12):1455-1462. doi: 10.1007/s00702-024-02822-x. Epub 2024 Aug 19.

Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction.颠覆帕金森病认知的革命：海因茨·赖希曼博士的开拓性研究与未来研究方向。

J Neural Transm (Vienna). 2024 Dec;131(12):1367-1387. doi: 10.1007/s00702-024-02812-z. Epub 2024 Aug 7.

L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.左旋多巴治疗帕金森病：来自维也纳和柏林的关于左旋多巴治疗的一些个人思考。

J Neural Transm (Vienna). 2023 Nov;130(11):1323-1335. doi: 10.1007/s00702-023-02692-9. Epub 2023 Oct 5.

Recent advances in cancer metabolism: a technological perspective.癌症代谢的最新进展：技术视角。

Exp Mol Med. 2018 Apr 16;50(4):1-16. doi: 10.1038/s12276-018-0027-z.

Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.酪氨酸羟化酶（TH）、其辅因子四氢生物蝶呤（BH4）、其他儿茶酚胺相关酶及其人类基因与帕金森病（PD）的药物和基因治疗：历史概述与未来展望

J Neural Transm (Vienna). 2016 Nov;123(11):1255-1278. doi: 10.1007/s00702-016-1596-4. Epub 2016 Aug 4.

Reversible Pharmacological Induction of Motor Symptoms in MPTP-Treated Mice at the Presymptomatic Stage of Parkinsonism: Potential Use for Early Diagnosis of Parkinson's Disease.在帕金森病症状前期阶段，MPTP 处理的小鼠中运动症状的可逆药理学诱导：对帕金森病早期诊断的潜在用途。

Mol Neurobiol. 2017 Jul;54(5):3618-3632. doi: 10.1007/s12035-016-9936-9. Epub 2016 May 19.

The Human Experience with Intravenous Levodopa.静脉注射左旋多巴的人体试验经历

Front Pharmacol. 2016 Jan 6;6:307. doi: 10.3389/fphar.2015.00307. eCollection 2015.

本文引用的文献

[ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].[左旋多巴治疗帕金森综合征及利血平所致帕金森症的附加实验研究]

Arch Psychiatr Nervenkr. 1964 Dec 2;206:367-81. doi: 10.1007/BF00341704.

EVIDENCE FOR A ROLE OF DOPAMINE IN EXTRAPYRAMIDAL FUNCTIONS.多巴胺在外周锥体外系功能中作用的证据。

Acta Neuroveg (Wien). 1964 Oct 2;26:484-93. doi: 10.1007/BF01252144.

BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE.酪氨酸羟化酶抑制剂α-甲基酪氨酸对内源性去甲肾上腺素合成的阻断作用

J Pharmacol Exp Ther. 1965 Jan;147:86-95.

[NEW MEANS OF CONTROLLING EXTRAPYRAMIDAL MOTOR DISORDERS].

Arzneimittelforschung. 1964 Jun;14:SUPPL:599-601.

[THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].[左旋多巴在接受和未接受立体定向脑手术的帕金森病患者中的疗效]

Arch Psychiatr Nervenkr. 1964 Jun 1;205:281-92. doi: 10.1007/BF00395715.

Dihydroxyphenylalanine in extrapyramidal disease.锥体外系疾病中的二羟基苯丙氨酸

JAMA. 1963 Apr 27;184:285-6. doi: 10.1001/jama.1963.73700170010010c.

[The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].[正常人及帕金森病患者黑质中去甲肾上腺素和多巴胺（3-羟酪胺）的热带定位及含量]

Wien Klin Wochenschr. 1963 May 3;75:309-12.

Dopamine metabolism in Parkinson's disease.帕金森病中的多巴胺代谢

Neurology. 1963 Jan;13:73-6. doi: 10.1212/wnl.13.1.73.

[On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study].[关于左旋多巴对帕金森综合征运动障碍的影响。一项肌电图研究]

Wien Z Nervenheilkd Grenzgeb. 1962;20:90-100.

[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].[左旋多巴（L-3,4-二羟基苯丙氨酸）对帕金森氏症运动不能的作用]

Wien Klin Wochenschr. 1961 Nov 10;73:787-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验